Genprex, Inc. Gains 110.76%

Tue, Mar 17, 2020 at 05:42 PM

Genprex, Inc. (GNPX:NASDAQ) soared at $3.33, representing a gain of 110.8%. On Mon 16 Mar 20, GNPX:NASDAQ touched a New 2-Week Low of $1.58. The stock got featured on our News Catalysts scanner on Wed 04 Mar 20 at 08:33 PM in the 'MISCELLANEOUS' category. From Mon 02 Mar 20, the stock recorded 10.00% Up Days and 9.09% Green Days

About Genprex, Inc. (GNPX:NASDAQ)

Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.

Top 10 Gainers:

Sundance Energy, Inc. (SNDE:NASDAQ), 265%
GTY Technology Holdings Inc. (GTYH:NASDAQ), 177.01%
Global Eagle Entertainment Inc. (ENT:NASDAQ), 143.48%
Genprex, Inc. (GNPX:NASDAQ), 110.76%
Zovio Inc (ZVO:NASDAQ), 81.08%
Blue Apron Holdings, Inc. (APRN:NYSE), 71.47%
Capital Bancorp, Inc. (CBNK:NASDAQ), 69.91%
NextDecade Corporation (NEXT:NASDAQ), 66.94%
BioNTech SE (BNTX:NASDAQ), 66.5%
Synlogic, Inc. (SYBX:NASDAQ), 63.75%